Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Haleon, Pfizer
Pfizer to sell $3 billion stake in Sensodyne maker Haleon
Pfizer is looking to sell about 700 million ordinary shares in Haleon , its bookrunner J.P. Morgan said on Tuesday, lowering its stake in the British consumer healthcare company to about 7.3% from 15%.
Why Pfizer sold its $3 billion stake in Haleon
Pfizer’s decision to offload $3.05 billion worth of shares in Haleon is a strategic move driven by shifting priorities in a volatile pharmaceutical market. The transaction, involving 700 million shares priced at 357 pence each,
Pfizer Sells 700 Million Haleon Shares for $3.05 Billion
The sale decreases Pfizer’s shareholding in the consumer-healthcare business to 7.3% of its issued share capital, down from 15%.
Pfizer Has Sold 700M Haleon Shares
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing opportunities, strengthen advisor-client relationships and build investor experiences. Learn More. Back To Top
Hosted on MSN
1d
Pfizer believes in the metaverse: will healthcare thaw the technology’s winter?
The metaverse hype is over, but developer Cassette Group has been working with Pfizer to realise its forgotten potential.
20h
EU ‘declares war’ on toxic chemicals: why big pharma and IT giants could flee Ireland for the US
The US could be the beneficiary of a potential blanket ban on the use of PFAS, better known as ‘forever chemicals’.
4d
Pfizer appeals denial of $75 million claim in SEC case against Cohen hedge fund
Pfizer on Tuesday appealed a federal judge's refusal to award the drugmaker $75.2 million from a more than decade-old insider ...
WBIW
2d
Pharmaceutical companies spike EpiPen prices 600% while allegedly deceiving Hoosier consumers
Attorney General Todd Rokita has filed a lawsuit alleging that Mylan and Pfizer have conspired to increase EpiPen’s price by ...
FiercePharma
4d
JPM25: BMS, Pfizer and Merck CEOs address key patent cliffs and plans to replace sales
Monday, three Big Pharma leaders took center stage and addressed concerns about future patent expirations head-on.
Pharmaceutical Technology on MSN
5d
Pfizer pitches pipeline priorities in oncology and obesity at JP Morgan 2025
CEO Albert Bourla expressed modest optimism for Pfizer’s 2025 revenues at JPM 2025, supported by plans to prioritize R&D in oncology and obesity.
BioSpace
4d
Pfizer Cautiously Optimistic on Obesity Pill as Kailera Challenges Lilly’s Zepbound With Strong Phase II Data
Obesity continues to grab attention at the J.P. Morgan Healthcare Conference in San Francisco, with both Pfizer and Kailera ...
WDRB
2d
Indiana's attorney general sues 2 pharmaceutical companies over EpiPen costs
The lawsuit filed Thursday in Marion County Superior Court accuses Mylan and Pfizer of conspiring to raise the price of ...
pharmaphorum
1d
Changing Faces: Pharma and biotech November-December 2024
Pfizer named Dr Chris Boshoff as CSO and president of R&D, effective 1st January 2025. Boshoff, previously Pfizer’s chief ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback